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396Objective: Few data are available on the frequency or importance of perioperative atrial tachycardia in infants.
We hypothesized that atrial tachycardia in infants undergoing cardiac surgery is not rare and is associated with
increased morbidity and mortality.
Methods: From 2007 through 2010, 777 infants (median age, 1.8 months; interquartile range, 0.33–5.73) un-
derwent cardiac surgery. Their medical records were reviewed for atrial tachycardia during the perioperative
period.
Results: Of the 777 patients, 64 (8.2%) developed atrial tachycardia. The independent risk factors for develop-
ing atrial tachycardia included surgical age 6 months or younger (odds ratio, 4.4; 95% confidence interval,
1.1–19.15), use of 3 or more inotropes (odds ratio, 2.9; 95% confidence interval, 1.4–6.2), and heterotaxy syn-
drome (odds ratio, 2.9; 95% confidence interval, 1.1–7.4). All-cause mortality in the atrial tachycardia group
was increased (21.9% vs 7.2%, P<.001) during a median follow-up period of 14.6 months (interquartile range,
6.8–24.6), and atrial tachycardia was independently associated with decreased survival (hazard ratio, 1.9; 95%
confidence interval, 1.1–3.8). Infants with perioperative atrial tachycardia had a longer hospital length of stay
(32 vs 17 days, P<.001) and duration of inotrope use (10.5 vs 3.0 days, P<.001). A total of 57 patients received
antiarrhythmic therapy, with propranolol the most common (n¼ 31). Among the survivors, 48 patients received
outpatient antiarrhythmic therapy, which was successfully discontinued in 23 patients at a median duration of 14
months (interquartile range, 5.7–18.6) without recurrence.
Conclusions: Atrial tachycardia is common in infants undergoing cardiac surgery and is independently associ-
ated with decreased survival. Among survivors, antiarrhythmic agents successfully controlled atrial tachycardia
in most patients with a low recurrence risk after discontinuation. (J Thorac Cardiovasc Surg 2012;144:396-401)Earn CME credits at
http://cme.ctsnetjournals.org
Among infants undergoing corrective or palliative cardiac
surgery, the incidence of perioperative tachyarrhythmias
has been reported to be 14% to 60%.1-3 Cardiac
dysfunction, the postoperative effects of cardiopulmonary
bypass, the presence of scar and suture within the
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The Journal of Thoracic and Cardiovascular Surgfactors have all been postulated as risk factors for increased
rates of postoperative arrhythmia.1,4-6
Focal atrial tachycardia (AT) is a form of supraven-
tricular arrhythmia that occurs in infants with and with-
out congenital heart disease.7-10 Although previous
reports have described longer hospital stays, intubation
times, and requirement for inotropic support in infants
with perioperative cardiac arrhythmias,2,11 only limited
data have described the risk factors and outcome of
perioperative AT in infants undergoing cardiac surgery.
Furthermore, the mortality associated with AT has not
been reported in this age group. Therefore, the present
study aimed to test the hypothesis that AT in infants
undergoing cardiac surgery is not a rare occurrence
and is associated with increased morbidity and
mortality. The risk factors associated with AT were
also assessed.METHODS
A retrospective review of the pediatric cardiovascular surgery database
identified all infants who underwent cardiac surgery at Texas Children’s
Hospital from July 2007 through July 2010. The medical records of these
infants were then reviewed in the pediatric cardiology database to identify
those diagnosed with AT within the perioperative period. The Baylor
College of Medicine institutional review board approved the study.ery c August 2012
Abbreviations and Acronyms
AT ¼ atrial tachycardia
CI ¼ confidence interval
ECMO ¼ extracorporeal membrane oxygenation
IQR ¼ interquartile range
OR ¼ odds ratio
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All infants who underwent cardiac surgery during the study period were
included. This included all infants with structural heart disease and those
who required placement of a ventricular assist device or cardiac transplan-
tation. We excluded infants who underwent pacemaker implantation for
congenital atrioventricular block, pericardial window creation for recurrent
pericardial effusion, or extracorporeal membrane oxygenation cannulation
for cardiopulmonary failure without concomitant cardiac surgery. All in-
fants were admitted to the cardiac intensive care unit postoperatively, re-
ceived continuous cardiac telemetry during their intensive care unit stay,
and had at least 1 electrocardiogram recorded postoperatively. The medical
records were reviewed for cases of AT. All cases were confirmed byFIGURE 1. A, Postoperative 12-lead electrocardiogram of an infant with atrial
of an infant with atrial tachycardia.
The Journal of Thoracic and Caa pediatric electrophysiologist. Macroreentrant AT such as atrial flutter
and fibrillation was not included.Definitions
Infancy was defined as patient age younger than 12 months. The perio-
perative period spanned 10 days preoperatively to 30 days postoperatively.
The diagnosis and procedural variables were stratified using the Risk Ad-
justment for Congenital Heart Surgery scoring system.12
ATwas defined as 3 or more consecutive beats of tachycardia originat-
ing from an alternative atrial focus different than sinus. To be included in
the present study, the degree of ATwas considered to be of enough clinical
significance by the attending cardiologist of record to require therapy alter-
ation, including initiation of antiarrhythmic treatment or close electrocar-
diographic observation. For the purposes of the present study, because
single 3-beat runs of tachycardia were typically not treated, they were
not included in the present study. Features aiding in the identification of
AT included an acute change in P wave morphology during tachycardia
at a rate at least 20% faster than sinus. In cases of heterotaxy syndrome,
care was taken to accurately identify AT in the presence of more than 1 pri-
mary atrial rhythm. A review of inpatient electrocardiographic telemetry or
24-hour Holter monitor data was performed independently by a pediatric
cardiac electrophysiologist (J.J.K.) to confirm the diagnosis. A representa-
tive 12-lead electrocardiogram and atrial electrocardiogram are displayedtachycardia. B, Postoperative atrial electrocardiogram (attached to lead V1)
rdiovascular Surgery c Volume 144, Number 2 397
TABLE 1. Patient demographics
Demographic
No AT
(n ¼ 713)
AT
(n ¼ 64) P value
Age (mo) <.001
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perioperative period were assigned to the study group, and all other patients
were assigned to the control group. The choice of management, including
type of antiarrhythmic agent, was at the sole discretion of the attending car-
diologist of record at the onset of AT.Median 2.37 0.27
IQR 0.39–6.00 0.20–1.23
Male gender (n) 391 (54.8) 42 (65.6) .06
Ethnicity (n)
Asian 25 (3.5) 1 (1.6) NS
Black 99 (13.9) 9 (14.1) NS
Hispanic 262 (36.7) 33 (51.6) .02
White 327 (45.9) 21 (32.8) .03
Prematurity (n) 153 (21.5) 15 (23.4) NS
Birth weight (kg) NS
Median 3.0 3.0
IQR 2.59–3.35 2.71–3.39
Weight at surgery (kg) <.001
Median 4.0 3.2Data Collection and Statistical Analysis
The preoperative and postoperative data were obtained by a review of
medical records at Texas Children’s Hospital. The intraoperative data
were obtained from the pediatric cardiovascular surgery database. Univari-
able analysis of categorical variables was performed using Pearson’s
chi-square or Fisher’s exact test, as appropriate. Continuous variables
were analyzed using the Mann-Whitney U test because the data were not
normally distributed. Survival analysis was performed using Kaplan-
Meier estimation. Factors significantly associated with the development
of ATand mortality were subsequently analyzed in multivariable analyses.
Multivariable binary logistic regression analysis was used to determine the
independent risk factors for developing AT, and Cox regression analysis
was used to determine the independent risk factors for mortality.
A 2-tailed test of significance was used for all statistical analyses.
IQR 3.11–6.10 2.79–3.72
Single ventricle anatomy (n) 150 (21.0) 25 (39.1) <.001
RACHS-1 score  4 (n) 198 (27.8) 37 (57.8) <.001
Diagnosis (n)
Ventricular septal defect 105 (14.7) 2 (3.1) <.001
Tetralogy of Fallot 83 (11.6) 2 (3.1) .02
Atrioventricular septal defect 73 (10.2) 3 (4.7) NS
Hypoplastic left heart syndrome 55 (7.7) 10 (15.6) .03
Coarctation of aorta 49 (6.9) 2 (3.1) NS
Transposition of great arteries 38 (5.3) 9 (14.1) .01
Heterotaxy syndrome 33 (4.6) 11 (17.2) <.001
Total anomalous pulmonary
venous return
29 (4.1) 7 (10.9) .02
Cardiopulmonary bypass time (min) n ¼ 530 n ¼ 53 NS
Median 168.5 182
IQR 121–216 135.5–231
Aortic crossclamp time (min) n ¼ 508 n ¼ 51 NS
Median 96 94RESULTS
Patient Population
A total of 777 infants at a median age of 1.8 months (in-
terquartile range [IQR], 0.33–5.73) who underwent cardiac
surgery at Texas Children’s Hospital during the study period
were included. Of those, 64 infants (8.2%) were diagnosed
with AT. Significant residual cardiac lesions requiring reop-
eration or catheter-based intervention within the postopera-
tive study period was relatively uncommon and was present
in 19 patients (2.4%, 5 in the AT group). The common
diagnoses and patient characteristics of both groups are
listed in Table 1. AT was more common in Hispanics
(P ¼ .02). The median age and weight at surgery were sig-
nificantly lower for patients with AT than for the control
group (P<.001 and P<.001, respectively).IQR 69.3–129 67–139
Antegrade cerebral perfusion time
(min)
n ¼ 113 n ¼ 27 NS
Median 56 66
IQR 25–84 37.8–79.8
Deep hypothermic circulatory arrest
time (min)
n ¼ 115 n ¼ 16 <.001
Mean 13 18
IQR 8–23 8–39
Data in parentheses are percentages. AT, Atrial tachycardia; IQR, interquartile range;
RACHS-1, Risk Adjustment for Congenital Heart Surgery.Presence of AT
Of the 777 patients, 64 (8.2%) were diagnosed with AT
and were included in the study group. Of these 64 patients,
8 (12.5%) developed AT at a median of 4.0 days (IQR,
0–6.0) preoperatively, and 56 (87.5%) developed AT at
a median of 8.5 days (IQR, 3.0–14.0) postoperatively. The
mean maximal rate of tachycardia was 241.2 beats/min
(range, 160–369) at a median of 7.0 days (IQR,
0.25–12.0) postoperatively. The factors associated with
the development of AT on univariable and multivariable
analysis are listed in Table 2. Onmultivariable analysis, het-
erotaxy syndrome, age at surgery younger than 6 months,
the use of 3 or more inotropes, total anomalous pulmonary
venous return, and transposition of the great arteries were
independent risk factors for the development of AT.
On univariable analysis, the specific inotropes used
during the perioperative period were associated with an
increased risk of postoperative AT. The preoperative use
of dopamine (odds ratio [OR], 2.97; 95% confidence398 The Journal of Thoracic and Cardiovascular Surginterval [CI], 1.17–7.56) or calcium chloride (OR, 3.38;
95% CI, 1.4–8.15) was significantly associated with an in-
creased risk of AT. Postoperatively, epinephrine (OR,
5.59; 95% CI, 2.98–10.12), vasopressin (OR, 3.37; 95%
CI, 2.01–5.67), and calcium chloride (OR, 4.36; 95%
CI, 2.51–7.57) use were significant. Milrinone did not sig-
nificantly contribute any additive risk to the development
of AT. Although no individual inotrope was significantly
associated with the development of AT on multivariableery c August 2012
TABLE 2. Risk factors for developing AT
Factor
Univariable
analysis
Multivariable
analysis
OR 95% CI OR 95% CI
Age  6 mo at surgery 10.47 2.54–43.23 4.41 1.05–19.15
Total anomalous pulmonary
venous return
2.90 1.22–6.90 3.07 1.11–8.50
Use of  3 inotropes 5.92 3.33–10.54 2.91 1.37–6.19
Heterotaxy syndrome 4.28 2.05–8.94 2.89 1.13–7.39
Transposition of great arteries 2.91 1.34–6.32 2.66 1.10–6.42
Single ventricle physiology 2.41 1.41–4.10 1.64 0.76–3.57
Hispanic 1.83 1.10–3.06 1.56 0.89–2.75
RACHS-1 score  4 3.76 2.21–6.41 1.55 0.78–2.95
Use of preoperative inotropes 2.17 1.13–4.17 1.03 0.48–2.21
Hypoplastic left heart syndrome 2.22 1.07–4.59 0.90 0.32–2.52
Use of postoperative inotropes 2.55 1.12–5.69 0.81 0.31–2.09
OR, Odds ratio; CI, confidence interval; RACHS-1, Risk Adjustment for Congenital
Heart Surgery.
TABLE 4. Risk factors for mortality
Factor
Univariable
analysis
Multivariable
analysis
HR 95% CI HR 95% CI
Use of preoperative inotropes 3.59 2.09–6.17 2.59 1.43–4.68
Perioperative AT 3.49 1.92–6.33 1.90 1.05–3.77
Use of postoperative inotropes 2.37 1.07–5.22 1.90 0.79–4.57
Heterotaxy syndrome 2.84 1.4–5.75 1.72 0.79–3.71
Single ventricle physiology 2.62 1.59–4.33 1.64 0.91–2.96
Age  6 mo at surgery 2.73 1.18–6.35 1.46 0.65–4.44
Hispanic 1.73 1.05–2.85 1.46 0.86–2.46
RACHS-1 score  4 3.15 1.84–5.41 1.45 0.8–2.65
HR, Hazard ratio; CI, confidence interval; AT, atrial tachycardia; RACHS-1, Risk Ad-
justment for Congenital Heart Surgery.
Shamszad et al Congenital Heart Disease
C
H
Danalysis, the use of 3 or more inotropes was significant
(OR, 2.91; 95% CI, 1.37–6.19; Table 2).
Patient Outcomes
Patients with AT had longer hospital stays and inotrope
durations compared with the non-AT group (Table 3). A to-
tal of 15 patients (1.9%), 10 control patients and 5 study pa-
tients (P ¼ .01), required extracorporeal membrane
oxygenation (ECMO) support during the postoperative pe-
riod owing to hemodynamic instability of differing etiolo-
gies. Incessant AT was the indication for ECMO in only 1
neonate, who initially required 72 hours of support, but
went on to an uneventful discharge home. Although the re-
maining 4 study patients developed AT sometime during the
perioperative period after ECMO decannulation, the indica-
tion for ECMO postoperatively was an acute, nonarrhyth-
mic cause of hemodynamic compromise.
The overall mortality of the study group was 21.9%
versus 7.2% in the control group (P< .001) during the
follow-up period. The median follow-up was 12.3 months
(IQR, 4.5–24.5) in the AT group and 14.7 monthsTABLE 3. Patient outcomes
Demographic
No AT
(n ¼ 713)
AT
(n ¼ 64) P value
Overall all-cause mortality (n) 51 (7.2) 14 (21.9) <.001
30-d Postoperative mortality (n) 13 (1.8) 3 (4.7) NS
30-d Readmission (n) 82 (11.5) 5 (7.8) NS
Hospital length of stay (d) <.001
Median 17 32
IQR 9–31 19.8–69.5
Inotrope duration (d) <.001
Median 3 10.5
IQR 1–8 6–26.5
Postoperative ECMO (n) 10 (1.4) 5 (7.8) .01
Data in parentheses are percentages. AT, Atrial tachycardia; ECMO, extracorporeal
membrane oxygenation.
The Journal of Thoracic and Ca(IQR, 7.0–24.7) in the non-AT group (P ¼ 0.21). On multi-
variable analysis, perioperative ATwas independently asso-
ciated with a greater risk of mortality (Table 4). Within the
study group, 8 patients died before discharge home; how-
ever, the mortality during the immediate 30-day postopera-
tive period was similar between the 2 groups. No
statistically significant difference was seen in the risk of
mortality between patients who developed AT preopera-
tively versus postoperatively (P ¼ 0.25). The Kaplan-
Meier survival curves for both groups and the log-rank
test of significance are displayed in Figure 2.
Antiarrhythmic Therapy
A total of 57 patients (89.1%) received inpatient antiar-
rhythmic therapy at the onset of AT. Propranolol was the
most commonly used agent in 31 (54.4%) patients, procai-
namide in 11 (18.9%), esmolol in 7 (12.1%), amiodarone
in 5 (8.8%), propranolol with digoxin in 2 (3.5%), and
metoprolol in 1 (1.7%). Treatment failure occurred in 13
patients. The initial therapy with propranolol failed in 10
patients and required transition to sotalol in 6 patients and
amiodarone in 4 patients. Esmolol therapy failed in 2FIGURE 2. Kaplan-Meier survival curve of infants with perioperative
atrial tachycardia compared with those without atrial tachycardia.
rdiovascular Surgery c Volume 144, Number 2 399
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cainamide therapy failed in 1 patient, who was transitioned
to amiodarone. Treatment failure was not significantly asso-
ciated with death (P¼ 0.26). The decision to not treat AT in
7 patients was predominantly because of the identification
of reversible iatrogenic causes such as the presence of
a deep central venous catheter or electrolyte derangement.
One untreated patient died before discharge and the remain-
ing 6 were successfully discharged with no antiarrhythmic
therapy and no recurrence of AT to date.
Of the 56 survivors at hospital discharge, 48 (85.7%) re-
ceived outpatient antiarrhythmic therapy. Propranolol was
again the most commonly used agent in 32 patients
(66.7%). Sotalol was used in 7 (14.6%), amiodarone in 5
(10.4%), propranolol with amiodarone in 2 (4.2%), pro-
pranolol with digoxin in 1 (2.1%), and metoprolol in 1
(2.1%). Antiarrhythmic therapy was successfully discon-
tinued in 23 patients (41.0%) at a median follow-up of
14.1 months (IQR, 5.7–18.6) without recurrence.
DISCUSSION
In the present retrospective study of 777 infants undergo-
ing cardiac surgery, perioperative AT developed in 8% of
the infants and was independently associated with increased
mortality, a finding not previously reported in the current lit-
erature. In the AT group, all-cause mortality was 21.9%
compared with 7.2% in the control group during a median
follow-up period of 16 months. Similar to a recent study by
Trivedi and colleagues13 describing arrhythmias in children
with hypoplastic left heart syndrome, we did not find a sig-
nificant difference in 30-day mortality between the AT and
control groups. This is in contrast to a previous investigation
examining all arrhythmias.2 However, no study to date,
including the 2 aforementioned reports, has examined AT
and its associated mortality. An analysis of inpatient mortal-
ity did not reveal the cause of death to be directly attribut-
able to AT. It would be difficult to ascertain whether AT
directly led to death in patients with out-of-hospital events
because their heart rhythm was not recorded at the event;
however, it is unlikely that ATwas the direct cause of death
in these patients. We hypothesized that the association of
AT with mortality is likely a surrogate marker of overall
poor cardiovascular health and not a direct result of the
arrhythmia.
A number of independent risk factors for developing AT
were identified including age 6 months or younger at sur-
gery, the use of 3 ormore inotropes, transposition of the great
arteries, total anomalous pulmonary venous return, and het-
erotaxy syndrome. Although Rosales and colleagues11 re-
ported univariable associations between postoperative AT
and both inotrope use and transposition of the great arteries,
the present study is the first to report independent risk fac-
tors. Similar to previous studies, younger age continued to
be a risk factor for ectopic automatic arrhythmias in infants400 The Journal of Thoracic and Cardiovascular Surgfrom unknownmechanisms.1,2,6 The arrhythmogenic nature
of inotropic agents and increased catecholamine levels
might enhance atrial automaticity and thus providing the
substrate to develop AT. Although the patient receiving 3
or more inotropes likely has morbidities beyond AT alone,
those who develop AT with significant inotropic support
likely represent an at-risk population of patients with com-
parably worse cardiovascular health. It is important to note
that AT was associated with mortality, independent of all
studied variables, including inotropic support. Thus, the pa-
tient receiving 3 or more inotropes who did not develop AT
was at a decreased risk of death compared with those who
did develop AT, suggesting that inotropes alone do not ex-
plain the increased risk of mortality in these patients.
Although the use of epinephrine, calcium chloride, dopa-
mine, and vasopressin in the perioperative period was asso-
ciated with AT, the use of milrinone was not, in contrast to
a recent report by Smith and colleagues.14 Thus, the combi-
nation of inotropes and the failing heartmightmanifest itself
as AT, representing a marker of overall poor cardiovascular
health and prognosis.
Specific diagnoses, including heterotaxy syndrome, were
associated with AT. Heterotaxy syndrome is often associ-
ated with complex congenital heart disease and atrial isom-
erism. Previous studies have reported the prevalence of
arrhythmias in both right15 and left16 atrial isomerism. Al-
though the development of AT in these patients is likely
multifactorial owing to the presence of associated anatomic
cardiac lesions, the present study was not designed to ex-
plore the mechanistic etiologies of AT. Furthermore, the in-
fants in the present study who developed AT did so at
a median of 8.5 days postoperatively, which might be later
than expected if the inciting factor responsible for the onset
of AT was simply surgical trauma. This later time of onset
might speak to an etiology and natural history different
from trauma, such as inflammatory mechanisms, anatomic
substrates, or a failing myocardium. Potential additional in-
vestigationmight help to better elucidate the possible mech-
anistic etiologies for the development of AT, as well as
possible therapeutic strategies to minimize untoward out-
comes. The recognition and diagnosis of AT in this sub-
group is difficult owing to the abnormal, multiform P
waves. Therefore, vigilant observation of abnormal heart
rates that acutely change, the ‘‘warm up and cool down’’
characteristics of the tachycardia, P wave morphology anal-
ysis, and atrioventricular conduction is needed to properly
make the diagnosis.
ATwas associated with significantly increased morbidity,
including increased hospital length of stay and total ino-
trope duration. This is likely a factor of the infant’s overall
cardiovascular state and not directly attributable to AT
alone. The 30-day readmission rate was not significantly
different statistically between the 2 groups. Although the
use of postoperative ECMO was more likely in the studyery c August 2012
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5 patients.
In our cohort, AT was successfully treated with antiar-
rhythmic agents, as determined by follow-up Holter moni-
toring demonstrating no recurrent AT. Inpatient therapy
with b-blockade, using propranolol and esmolol, was
most commonly used, followed by procainamide and amio-
darone. Treatment failure or the lack of treatment was not
associated with death. Outpatient therapy was equally
effective in the outpatient setting and can be successfully
discontinued in most patients with a low risk of recurrence.
Study Limitations
Although this was the largest study of infants with perio-
perative AT to date, the study was limited by its single-
center, retrospective design of a moderate number of
patients. This sample size made it difficult to exclude the
possibility of a type II error for other factors associated
with mortality. Although overall mortality was worse in
the AT group, the small sample size of the AT group was
of limited statistical power to show a statistically significant
difference in 30-day mortality between the 2 groups. In the
subgroup analyses, considerations regarding the predictive
risk factors were also of limited statistical power. The po-
tential for selection bias also exists because sicker infants
with closer monitoring might have had more frequent detec-
tion of AT than their healthier counterparts.
In conclusion, AT is an independent risk factor for mor-
tality among infants undergoing cardiac surgery. It was ob-
served during the perioperative period in 8% of infants
undergoing cardiac surgery and was more common among
infants aged 6 months or younger at surgery, those receiving
3 or more inotropes, and those with heterotaxy syndrome.
Among the survivors, antiarrhythmic agents successfully
controlled AT in most patients with a low recurrence risk af-
ter discontinuation. Additional study is needed to under-
stand the influence of AT on outcome in this population.The Journal of Thoracic and CaReferences
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